研報掘金丨平安證券:東鵬飲料Q1業績表現亮眼,維持“推薦”評級
平安證券研報指出,東鵬飲料(605499.SH)25Q1實現歸母淨利潤9.80億元,同比增加47.62%。費用管控得當,利潤率持續提升。能量飲料主業穩健,打造多品類矩陣。 分產品看,公司主營業務收入主要來自能量飲料,25Q1能量飲料實現收入39.01億元,佔比達80.50%。公司不斷探索和拓展飲料新品類,已形成能量飲料和電解質飲料業務“雙引擎”,同時涵蓋茶飲料、植物蛋白類飲料、咖啡飲料等系列,形成全面且均衡發展的多品類產品矩陣。公司所處的功能飲料賽道景氣度高,產品全國化勢不可擋,第二增長曲線逐步培育,期待公司憑藉優勢大單品和全渠道精耕推動市佔率不斷提升。維持“推薦”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.